The following stocks represented some of the most successful speculative plays for the year:
: The maker of Invisalign benefited from a near-monopoly on invisible braces, seeing a 131% increase as it expanded its training to thousands of dentists globally. high risk stocks to buy 2017
: 2017 favored growth investors; U.S. growth stocks returned roughly 29.59%, more than double the 13.19% return of value stocks. 10 High-Risk, High-Reward Stocks to Buy for 2017 The following stocks represented some of the most
: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data. 10 High-Risk, High-Reward Stocks to Buy for 2017
: Aggressive investors also looked at high-yield dividend stocks such as AstraZeneca (AZN) and GameStop (GME) , which offered potential capital appreciation alongside dividends, though they carried elevated risk during market transitions. Key Market Drivers for 2017
: Despite a "chaotic news cycle," markets remained remarkably steady, allowing growth premiums to outperform value premiums significantly.
: A top performer in the S&P 500 with a 132% gain . High risk stemmed from a major corporate overhaul, where the company shed clean energy assets and cut costs under pressure from activist investors.